This inventor holds 8 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignees: Medafor, Inc., Chitogen Inc., Innovac Co.. Active years: 1997-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Minneapolis, MN (US) (1997 - 2018)
- Minnespolis, MN (US) (2021)
Company Filing History:
2 out of 4 
1 out of 1 
1 out of 1 
Years Active: 1997-2021
Title: James Franklin Drake: Innovator of Hemostatic Compositions
Introduction
James Franklin Drake is a prominent inventor based in Minneapolis, MN, known for his contributions to medical innovations, particularly in hemostatic compositions. With a total of eight patents to his name, Drake has specialized in creating advanced materials that improve blood coagulation and enhance wound care.
Latest Patents
Drake's most notable recent patents include a "Stable and Robust Blended Hemostatic Composition," which features a unique formulation blending collagen fibrils and starch particles into a fluffy mass that exhibits superior hemostatic properties. This innovative composition relies on its coherence, allowing it to maintain its structure while only minimally losing starch particles when handled.
Another significant patent involves the "Coherent Blood Coagulation Structure of Water-Insoluble Chitosan and Water-Dispersible Starch Coating." This invention includes a non-woven fabric layer made of water-insoluble chitosan fibers, coated with water-absorbent starch on at least one surface. This design effectively moderates blood flow from wounds, penetrating to a depth of at least 25% of the fabric layer, thus improving its absorbency and functionality.
Career Highlights
Throughout his career, James Franklin Drake has made notable advancements in the field of wound care materials. His work primarily focuses on developing compositions that enhance the body's natural ability to clot, crucial for effective medical treatment and recovery.
Collaborations
Drake has collaborated with esteemed colleagues such as Lynn R. Skow and Mark Harold Ereth during his tenure at Medafor, Inc. Their combined expertise has fostered innovative solutions in the domain of hemostatic technologies, contributing to the advancement of medical products in critical care settings.
Conclusion
James Franklin Drake continues to be a key player in the field of medical innovations, with a proven track record of impactful patents. His dedication to improving patient outcomes through advanced hemostatic compositions exemplifies the essence of ingenuity and perseverance in the pursuit of better healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile